
Heartseed Inc. — Investor Relations & Filings
Heartseed Inc. is a clinical-stage biotechnology company pioneering regenerative medicine for severe heart failure. The company's core technology involves the creation of high-purity cardiomyocytes (heart muscle cells) from induced pluripotent stem cells (iPS cells) to achieve cardiac 'remuscularization.' Its lead pipeline candidate, HS-001, is an allogeneic iPS cell-derived cardiomyocyte therapy administered via intramyocardial injection. This treatment is being developed for patients with heart failure with reduced ejection fraction (HFrEF), including those with dilated cardiomyopathy or old myocardial infarction, offering a potential alternative to heart transplantation. Heartseed is also advancing next-generation research using autologous and HLA-edited iPS cells to improve treatment outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 確認書 | 2026-03-26 | Japanese | |
| 有価証券報告書-第10期(2024/11/01-2025/12/31) | 2026-03-26 | Japanese | |
| 臨時報告書 | 2025-06-19 | Japanese | |
| 確認書 | 2025-06-12 | Japanese | |
| 半期報告書-第10期(2024/11/01-2025/12/31) | 2025-06-12 | Japanese | |
| 臨時報告書 | 2025-01-27 | Japanese |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 33045264 | 確認書 | 2026-03-26 | Japanese | ||
| 33045240 | 有価証券報告書-第10期(2024/11/01-2025/12/31) | 2026-03-26 | Japanese | ||
|
2025
7 filings
| |||||
| 7257355 | 臨時報告書 | 2025-06-19 | Japanese | ||
| 7259428 | 確認書 | 2025-06-12 | Japanese | ||
| 7259411 | 半期報告書-第10期(2024/11/01-2025/12/31) | 2025-06-12 | Japanese | ||
| 7287648 | 臨時報告書 | 2025-01-27 | Japanese | ||
| 7287647 | 確認書 | 2025-01-27 | Japanese | ||
| 7287649 | 有価証券報告書-第9期(2023/11/01-2024/10/31) | 2025-01-27 | Japanese | ||
| 7287644 | 内部統制報告書-第9期(2023/11/01-2024/10/31) | 2025-01-27 | Japanese | ||
|
2024
3 filings
| |||||
| 7315518 | 訂正有価証券届出書(新規公開時) | 2024-07-22 | Japanese | ||
| 7316729 | 訂正有価証券届出書(新規公開時) | 2024-07-11 | Japanese | ||
| 7326849 | 有価証券届出書(新規公開時) | 2024-06-26 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Viridian Therapeutics, Inc.\DE
Develops antibody-based therapies for serious and rare auto…
|
VRDN | US | Professional, scientific and te… |
|
VITRAFY LIFE SCIENCES LIMITED
Develops advanced cryopreservation and cold chain solutions…
|
VFY | AU | Professional, scientific and te… |
|
Viva Biotech Holdings
Integrated drug discovery, development, and manufacturing s…
|
1873 | KY | Professional, scientific and te… |
|
Viventia Biotech Inc.
Research and development of innovative, targeted oncology t…
|
— | CA | Professional, scientific and te… |
|
Vivo Bio tech Ltd.
Preclinical CRO providing drug discovery services and SPF l…
|
511509 | IN | Professional, scientific and te… |
|
VivoSim Labs, INC.
Develops 3D bioprinted human tissues for non-animal drug to…
|
VIVS | US | Professional, scientific and te… |
|
VOLITIONRX LTD
Epigenetics company developing blood tests for early diagno…
|
VNRX | US | Professional, scientific and te… |
|
Vor Biopharma Inc.
A clinical-stage biotech developing therapies that target t…
|
VOR | US | Professional, scientific and te… |
|
WDB coco CO.,LTD.
A CRO providing support services to the pharmaceutical and …
|
7079 | JP | Professional, scientific and te… |
|
Whitehawk Therapeutics, Inc.
A preclinical oncology company developing advanced antibody…
|
WHWK | US | Professional, scientific and te… |
Heartseed Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/14724/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=14724 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=14724 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=14724 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 14724}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Heartseed Inc. (id: 14724)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.